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Abstract
Background: The dried roots of Scutellaria baicalensis Georgi, is known in traditional Chinese medicine as Huang
Qin (H. qin), and it has been officially and traditionally used in treatment of various diseases such as hepatitis in
China. Baicalein (BA), a flavonoid originally isolated from H. qin, has shown a wide range of biological activities. This
study was to evaluate whether baicalein, can reduce the intestinal mucosal cell apoptosis caused by cirrhotic
endotoxemia and its possible mechanisms.
Methods: For this purpose, compound factors modeling was used to establish endotoxemic cirrhotic rat model.
Firstly, we evaluated endotoxin, ALT, AST and TBIL levels after the baicalein treatment (20 mg/kg, i.v.). To investigate
the mechanism of baicalein effect on apoptosis, TUNEL assay was used to detect intestinal mucosal apoptosis.
RT-PCR was used to detect the expression levels of gene Bcl-2 mRNA and Bax mRNA in intestinal mucosal tissues.
Caspase-3 activity of intestinal tissue was detected with colorimetric method in our experiments.
Results: After treatment with BA, the serum endotoxin concentration, the intestinal mucosal apoptosis rate and
the activity of caspase-3 of the baicalein group were significantly lower than that of the model and the
glutamine group. The serum ALT, AST and TBIL concentration of the BA group were significantly lower than that
of the model group. The body weight of the baicalein group was significantly lower than that of the normal
group, but it was higher than that of the model group. Among the treatment groups, the mRNA level of anti-apoptotic
gene Bcl-2 was the lowest in the model group and the highest in the baicalein group while the mRNA level of
pro-apoptotic gene Bax was the lowest in the baicalein group and the highest in the model group.
Conclusion: The present results demonstrated that baicalein could reduce the occurrence of cirrhotic
endotoxemia partly by reducing intestinal mucosal apoptosis.
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Background
Cirrhotic endotoxemia is an important factor causing
disease progression and multiple organ failures. There
are many studies on the formation mechanism of cir-
rhotic endotoxemia. When cirrhosis was formed, portal
hypertension caused hyperemia, edema, and erosion at
intestinal mucosa. Intestinal mucosal epithelial cell
apoptosis occurred. As a result, intestinal protection func-
tions decreased, and intestinal flora were displaced [1,2].
Then endotoxin went into the blood and endotoxemia was
formed, which was considered to be one of the main
causes for cirrhotic endotoxemia. Breakdown of intestinal
mucosal barrier function in cirrhotic endotoxemia is of
great clinical importance [3]. Liver cirrhosis is the initial
factor in this mechanism, but one of the key links to endo-
toxemia formation is the disappearance of intestinal muco-
sal integrity [4-6]. The present study demonstrated liver
cirrhosis was associated with the decrease of intestinal mu-
cosal proliferation and the ratio of proliferation/apoptosis
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even at the early stage of cirrhosis [7]. Therefore, one of
the effective methods in treating cirrhotic endotoxemia
might be reducing intestinal mucosal cell apoptosis.
The dried roots of Scutellaria baicalensis Georgi, is
known in traditional Chinese medicine as Huang Qin
(H. qin), and it has been officially and traditionally used
in treatment of various diseases such as hepatitis, pneu-
monia, jaundice, fever, and acute dysentery in China
[8,9]. Baicalein (BA), a flavonoid originally isolated from
H. qin, has shown a wide range of biological activities,
including antiendotoxic [10], anti-bacterial [11], anti-
hepatic fibrosis [11,12], anti-inflammatory [13-17], anti-
viral [18], etc. Previous studies have demonstrated that
BA had cytoprotective and anti-apoptotic effects in
myocardial cells [19], liver cells [20,21], lung fibroblasts
[22] >and cancer cell lines [23,24]. And it may regulate
apoptosis-related genes such as Bcl-2 and BAX etc.
[25,26]. And on the basis of this, our study will further
explore the anti-apoptotic effect of Baicalein on intes-
tinal mucosal epithelial cells and thus explore whether
the occurrence of cirrhotic endotoxemia could be re-
duced by decreasing intestinal mucosal cell apoptosis.
Methods
Experimental animals
90 healthy and clean Sprague Dawley rats were 8 weeks
old weighing 190–220 g, and all were purchased from
the Laboratory Animal Center of Xi’an Jiaotong University.
All animals were housed under controlled temperature
(23 ± 1) °C, humidity (55 ± 5) % and 12 h light/12 h dark
cycle for 1 week before the experiment.
Experimental materials
BA (purity 99 %) was purchased from Sigma-Aldrich
Chimie Company (Fallavier, France). Glutamine (Kotobuki
Pharmaceutical Co., Ltd.) was purchased from the phar-
macy of the First Affiliated Hospital of Xi’an Jiaotong
University. Carbon tetrachloride analytical reagent (AR)
was purchased from Chemical Reagent Branch of Tianjin
Zonghengxing Industrial and Trading Co., Ltd. Olive oil
(AR) was purchased from Sinopharm Chemical Reagent
Co., Ltd. Rat endotoxin quantitative detection kit was pur-
chased from Beijing Jinshanchuan Technology Develop-
ment Co., Ltd. Apoptosis detection kit was purchased
from Biosynthesis Biotechnology Co., Ltd. Total RNA ex-
traction kit was purchased from Takara Biotechnologh
(Da Lian) Co., Ltd. Caspase-3 activity detection kit was
purchased from Clontech company.
Reagent preparation
CCL4 oil solution preparation: 40 ml CCL4 was dis-
solved in 60 ml olive oil and 40 % CCL4 oil solution was
prepared and stored at room temperature.
30 % alcoholic beverage preparation: anhydrous etha-
nol and animal drinking water were prepared in propor-
tion of 3: 7 and stored at room temperature.
Glutamine solution: 15 g glutamine was dissolved 15 ml
distilled water and was prepared as 1 g/ml solution.
The establishment of endotoxemic cirrhotic rat model
Half of male and female Sprague-Dawley rats between
190 and 220 g were obtained from the Animal Research
Center of Xi’an Jiaotong University which were main-
tained according to the Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory Animal Re-
sources, 1996, Nat. Acad. Press) and approved by the
Xi’an Jiaotong University (Xi’an, China) Institutional
Animal Care and Use Committee (IACUC). At the end
of experiments, rats were euthanized under Phenobar-
bital anesthesia.
Endotoxemic cirrhotic rat model was established
through complex factor modeling method using carbon
tetrachloride combined with high-fat diet [27,28]. Con-
ventional adaptive feeding of animals was done for
1 week and then an eight-week fibrosis induction period
was initiated. All rats were randomly divided into model
control group with 80 rats and normal control group
with 10 rats. During the initial two-week treatment,
40 % CCL4 olive oil solution was biweekly subcutane-
ously injected for 0.5 ml/100 g body weight, combined
with high-fat diet (20 % lard oil +0.5 % cholesterol
+79.5 % corn flour) and 5 % ethanol (White wine and
distilled water) as drinking water, followed by two weeks
50 % CCL4 olive oil solution of biweekly subcutaneous
injection of 0.3 ml/100 g body weight, with high-fat diet
(0.5 % cholesterol +99.5 % corn flour) and 10 % ethanol
as drinking water. From the 5th to 8th week, 60 % CCL4
olive oil solution was biweekly subcutaneously injected
for 0.3 ml/100 g body weight, combined with high-fat
diet (0.5 % cholesterol +99.5 % corn flour) and 10 %
ethanol as drinking water (see in Fig. 1). At the 9th week,
5 rats of the model control group were randomly selected,
and their liver histopathology and serum endotoxin levels
were detected. After the establishment of endotoxemic
cirrhotic rat model was determined, follow-up tests were
conducted. During modeling, 15 endotoxemic cirrhotic
rats died due to liver failure, and the mortality rate was
18 %. No rats died in the normal control group.
Method of administration
After modeling, 60 rats of the model group were ran-
domly divided into 3 groups, namely BA treatment
group, the glutamine treatment control group and the
model control group with 20 rats in each group. In all
of BA treatment groups, rats were administered for
intravenous injection with BA (20 mg/kg [10]); Baica-
lin were mixed with Poloxamer according to the ratio
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of 1:5, and then after the mortar was used for grinding
for 20 min, 0.9 % NaCl was added. The solution was
adjusted to pH 7.4),and the rats were gavaged with
1 ml/100 g aqueous solution for two weeks. 1 ml/
100 g glutamine aqueous solution was drenched to the
rats of the glutamine group, and 1 ml/100 g aqueous
solution was drenched to the rats of model control
group. Moreover, the rats in the glutamine and model
control group also received an intravenous injection
with equivalent volume of 0.9 % saline for 2 weeks.
Specimen collection and preparation
At 14th day after treatment, i.e. fasting for 24 h after the last
administration, specimens were collected, and the specific
steps were as the following:
After rat body weight was recorded, 10 % 1 ml/100 g
chloral hydrate solution was used for anesthesia by in-
traperitoneal injection, and then the abdominal cavity
was opened under sterile conditions. Under pyrogen-
free conditions, abdominal aorta blood was collected
into depyrogenation tube and kept for enzyme linked
immunosorbent assay (ELISA) detection.
After blood collection, the liver was exposed, and
terminal ileum tissue of about 3 cm was taken from
the intestinal tract. One part of this intestinal tissue
was put in 4 % paraformaldehyde solution for TUNEL
assay,and the other part was put in liquid nitrogen for
later use.
Detection of serum endotoxin levels with two-step
double antibody sandwich enzyme-linked
immunosorbent assay
The enzyme linked immunosorbent assay (ELISA) was
used for the detection and quantification of serum endo-
toxin levels of rats in all groups according to the manu-
facturer’s description (range 2.5–80 pg/mL). Samples of
serum (100 μL) were dispensed into wells of 96-well
microlitre plates which had been pre-coated with rat
endotoxin (LPS) antibody. After a 30 min incubation at
37 °C, unbound proteins were washed away from the
wells. A protein-specific biotinylated antibody was then
added and the plates were incubated for 2 more hours at
37 °C. After further rinsing to remove unbound anti-
body, a substrate solution A, B was added to each well
and the mixture was incubated for 20 min at 37 °C. The
reaction was terminated with the addition of a stop solu-
tion. A value was read at 450 nm in microplate reader.
With a value as vertical coordinates and the standard
concentration as abscissa, standard curve was drawn.
According to the value of serum sample, its concentra-
tion was found at the standard curve, and the data were
expressed as mean value.
Serum ALT, AST and TBIL levels were detected with
ELISA method.
Detection of intestinal mucosal cell apoptosis by TUNEL
Terminal deoxynucleotide transferase dUTP nick end
labeling (TUNEL) was performed to detect cellular
apoptosis on terminal ileum tissue using in situ cell
death detection Kit according to the manufacturer’s in-
structions. Sections were post-fixed in ethanol-acetic
acid (2:1) and rinsed. Then the sections were incubated
with proteinase K (100 μg/mL), rinsed, incubated in 3 %
H2O2, and washed with PBS for 10 min followed by
washing with permeabilization solution (0.1 % Triton X-
100, 0.1 % sodium citrate) for 5 min. After the sections
were washed twice with PBS, incubated in TUNEL reac-
tion mixture,and rinsed again. Sections were visualized
using converter-POD with 0.02 % 3,3’-diaminobenzidine
(DAB). Mayer’s hematoxylin was used for counter-staining.
The sections were finally mounted onto gelatin-coated
slides and then they were air dried overnight at room
temperature. Yellow stained nucleus was TUNEL positive
cells.
TUNEL-positive cell quantitative method was used. In
each group, 5 cases of well-stained sections were se-
lected and magnified 10 times for observation under the
microscope objective. 5 high power fields (×400) in each
section were randomly selected, and a total of 25 high
power fields were photographed into computer (reso-
lution is 800× 600). Q550CW image signal acquisition
and analysis system was employed to calculate intestinal
epithelial cell apoptosis index. The number of apoptotic
A B
C D
Fig. 1 The pathological changes of liver tissue in the each group
after treatment (HE staining, 10 × 40). Note: a The pathological
changes of liver tissue in normal group; b The pathological changes
of liver tissue in Model group; c The pathological changes of liver
tissue in Glutamine treatment group; d The pathological changes of
liver tissue in BA treatment group
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cells / the total cell number × 100 % = the apoptosis rate
of this field, and the average rate of apoptosis of five
fields was the apoptosis rate of rat intestinal mucosal
cells in the group.
Detection of apoptotic gene Bcl-2 mRNA and Bax mRNA
by RT-PCR
Experimental procedures
Primer synthesis: According to Complementary DNA
(cDNA) sequence of Bcl-2, Bax and β-actin, two pairs of
primers were designed respectively. Bcl-2 upstream pri-
mer was 5’-GAACTGGGGGAGGATTGTGG-3 ’, and its
downstream primer was 5’-CCACCGAA CTCAAAGAA
GG-3’, and the product length was 269 bp; Bax upstream
primer was 5’-GTTACAGGG TTTCATCCAGG-3 ’, and
its downstream primer was 5’-CAAAGTAGAAGAGGG-
CAACC-3, and the product length was 272 bp; The
upstream primer of housekeeping gene β-actin was 5’-
AACCCT AAG GCC AAC CGT GAA AAG-3 ’, and its
downstream primer was 5’-TCATGAGGTAGTCTGT
CAG-3’, and the product length was 241 bp. All primers
were designed and synthesized by Beijing Aoke Company.
Total RNA extraction: After the rats were sacrificed,
dry roasted tweezers were used to clip terminal ileum
tissue of about 3 cm quickly from the intestinal tract. In-
testinal contents were rinsed with saline, and the tissues
were cut into 2 cm × 1 cm size and they were cooled
and preserved rapidly with liquid nitrogen. In the experi-
ment, 100 mg colon specimens were taken, and the tis-
sues were ground into power in liquid nitrogen. Total
RNA was extracted by Trizol reagent extraction method
with reference to the method on the kit.
RNA was reverse transcribed into cDNA. Reverse
transcription reaction was performed according to Invi-
trogen’s Superscript III First-Strand Synthesis reverse
transcription kit instructions. The product obtained was
stored at −20 °C or used directly.
Amplification of the housekeeping genes: PCR reaction
system (0.5 μl Taq DNA polymerase (5u/μl), 5 μl 5 ×
Buffer (1.5 mmol/L MgCl2), 1 μl P1 (100 μmol/l), 1 μl
P2 (100 μmol/l), 0.5 μl dNTP (10 mmol/l), 10 μl tem-
plate cDNA, 4 μl 50 mmol/L MgCl2, 28 μl H2O, and the
total reaction system was 50 μl). PCR reaction amplifica-
tion conditions: initial denaturation: 95 °C 30 s, denatur-
ation: 95 °C 30 s, renaturation: 58 °C 30 s, extension:
72 °C 30 s, 35 cycles, 72 °C for 10 min.
PCR amplification of gene fragments: reaction system
(0.5 μl Taq DNA polymerase (5u/μl), 5 μl 5 × Buffer
(1.5 mmol/L MgCl2), 1 μl P1 (100 μmol/l), 1 μl P2
(100 μmol/l), 0.5 μl dNTP (10 mmol/l), 10 μl template
cDNA, 4 μl 50 mmol/L MgCl2, 28 μl ddH2O, and the
total reaction system was 50 μl). PCR reaction amplification
conditions: initial denaturation: 95 °C 5 min, denaturation:
94 °C 45 s, renaturation: 56 °C 45 s, extension: 72 °C 45 s,
35 cycles, 72 °C for 10 min.
Electrophoresis was performed to PCR products in a
2 % agarose gel at 80 V for 30 min. Then PCR products
were observed and photographed in the gel imager, and
the Quantity One analysis system was used for the ana-
lysis of electrophoretic bands to calculate the values of
Bcl-2 products, Bax products and β-actin products, that
is, Bcl-2 and Bax mRNA expressions in tissues.
The above process was repeated three times.
The detection of caspase-3 activity of small intestinal
tissues with colorimetric method
100 mg fresh terminal ileum tissue was homogenized
and centrifuged, and protein concentration was deter-
mined and adjusted. DTT (1 mol/L 10 μl) of Caspase-3
detection kit and 50 μl 2 × reaction buffer were added
into 10ul supernatant sample protein, and then 10 μl
1 mmol Caspase-3 substrate Ac-DEVD-pNA was added.
The mixture was incubated at 37 °C for 60 min. The fluor-
escence units of Caspase-3 before and after incubation
were determined with excitation wavelength 400 nm and
emission wavelength 405 nm according to the instruction
of the kit. Lysis Buffer and reaction Buffer were taken as
the blank control.
Statistical methods
SPSS13.0 statistical analysis software package was used.
One-way analysis of variance (one-way ANOVA) was per-
formed, and q test (Student-Newman-Keuls test, S-N-K)
was used for pair wise comparisons. Data were all
expressed with (x  s), and when heterogeneity of variance
appeared, the data were square-root transformed. P <0.05
was considered to be statistically significant.
Results
Verification of endotoxemic cirrhotic rat model
During modeling, 15 rats of endotoxemic cirrhotic rat
model died due to liver failure, and the mortality rate
was 18 %. No rats died in the normal control group.
After modeling, five rats were randomly selected from
the model rats, and all had liver pathological examina-
tions and serum endotoxin level detection. Each of them
showed different degree of liver cirrhosis. Pathological
results showed that hepatic lobule structure was dam-
aged in model rats. Liver cell cords were no longer radi-
ating formation but arranged disorderly with obvious
swelling and degeneration –mostly fatty degeneration.
And the necrosis of some liver cells occurred, and in-
flammatory cell infiltration was obvious (see in Fig. 1b).
And for five model rats, the mean detection level of
endotoxin was 67.4 ± 22.6 pg/ml, and it was higher than
that in the formation of endotoxemic cirrhotic model re-
ported in the literature [29], and it was also higher than
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that of the normal control group. This confirmed the
modeling success of endotoxemic cirrhotic model.
After treatment, we also examined the liver patho-
logical changes of the BA and the glutamine treatment
groups. In the BA and the glutamine treatment groups,
part of the structure of hepatic lobule was not complete.
And the necrosis of some liver cells and inflammatory
cell infiltration seemed to be relatively minor in the BA
than that in the glutamine treatment group (Fig. 1c and d).
In Masson staining, blue color was hyperplastic collagen
fibers. In the normal group, rats’ hepatic lobule structure
was clear. In the model group, large amount of blue hy-
perplastic thick collagen fibers were observed in portal
area and lobules. Hepatic cell cords of liver lobule were ar-
ranged in disorder and a large amount of unequal-sized
pseudolobules were formed. In the BA group and the
Glutamine group, lesion degree was similar, collagen
fiber was less than that of the model group, the central
vein stellate was thickening, and some fibrous septum in
portal area was formed, but fibrous septum was thinner
than that of the model group. (Fig. 2)
Comparison of body weight of rats after intervention
Compared with the normal control group, body mass of
rats in the model group decreased significantly (P < 0.05).
Compared with the model group, body mass of rats in the
baicalin group significantly increased (P < 0.05). In the glu-
tamine group, body mass of rats also increased, but the
difference was not statistically significant (Table 1).
Comparison of endotoxin, ALT, AST and TBIL levels in
each group after intervention
Compared with the normal control group, the endotoxin
levels of all of experimental groups significantly in-
creased, (P <0.05). The serum endotoxin levels of the
model group increased from 67.4 ± 22.6 pg/ml at the
end of modeling to 115.12 ± 45.68 pg/ml, and it was
significantly higher than that of the BA treatment
group, (P <0.05). It was also higher than that of the glu-
tamine group, but there was no significant difference.
The serum endotoxin level of the BA treatment group
was significantly lower than that of the glutamine treat-
ment group, (P <0.05) (Table 2).
Compared with the normal control group, the ALT,
AST and TBIL levels of all of experimental groups sig-
nificantly increased, (P <0.05). The serum ALT, AST and
TBIL concentration of the BA treatment group were sig-
nificantly lower than that of the model group, (P <0.05)
(Table 2).
Detection of intestinal mucosal cell apoptosis in each
group by TUNEL
Intestinal mucosal cell apoptosis in normal rats was seen
occasionally (Fig. 2a). The intestinal mucosal cell apop-
tosis of endotoxemic cirrhotic rats significantly increased.
The positive nuclei were brown or black, and were scat-
tered diffusely in the field. The nuclei were pyknotic-like,
or chromatin aggregated to the surrounding, or the nuclei
were fragmentary (Fig. 2b). The intestinal mucosal cell
apoptosis of the BA group and the glutamine group in-
creased compared with that of the normal control group,
and the apoptotic nuclei were brown or black, but the in-
testinal mucosal cell apoptosis in these two groups signifi-
cantly improved compared with that in the model group,
and the improvement in the BA group was the most sig-
nificant (Fig. 2c and d).
The intestinal mucosal cell apoptosis rate of the ex-
perimental groups was significantly higher than that of
the normal control group, (P < 0.05). The intestinal mu-
cosal cell apoptosis rate of the model group was signifi-
cantly higher than that of the BA treatment group and
the glutamine group, (P < 0.05). The intestinal mucosal
A B
C D
Fig. 2 The pathological changes of liver tissue in the each group
after treatment (Masson’s trichrome stain, ×10). Note: a The
pathological changes of liver tissue in normal group; b The
pathological changes of liver tissue in Model group; c The
pathological changes of liver tissue in Glutamine treatment group; d
The pathological changes of liver tissue in BA treatment group
Table 1 Comparison of body weight of rats after intervention
(g) (x  s, g)
Groups Number body weight
Normal control group (NG) 10 426.11 ± 32.43 b
Model group (MG) 20 210.31 ± 18.45 a
Glutamine group (GG) 20 249.52 ± 16.70 a
BA group (BAG) 20 295.61 ± 23.48 a b
F endotoxin = 52.89, F ALT = 223.49, F AST = 223.49, F TBIL =234.90
aCompared with the normal control group, P < 0.05
bCompared with the model group, P < 0.05
cCompared with the glutamine group, P < 0.05
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cell apoptosis rate of the BA group was significantly
lower than that of the glutamine group, (P <0.05)
(Table 3).
Comparison of Bcl-2 mRNA level, Bax mRNA level and the
activity of caspase-3 in each group
RT-PCR reactions showed there was internal reference
β-actin band at 241 bp in each group (Fig. 3a). RT-PCR
results showed that there was a specific Bcl-2 band at
269 bp (Fig. 3b), and quantitative values were shown in
Table 4. Bcl-2 mRNA levels of intestinal mucosal tissues
in the experimental groups significantly decreased com-
pared with that of the normal control group, (P <0.05).
Bcl-2 mRNA levels of intestinal mucosal tissues in the
model group were significantly lower than that of the
BA treatment group and the glutamine treatment group,
(P < 0.05). Bcl-2 RNA level of intestinal mucosal tissue
in the BA treatment group was significantly higher than
that of the glutamine group, (P <0.05).
RT-PCR results showed that there was a specific Bax
band at 272 bp (Fig. 3c), and the quantitative values
were shown in Table 4. Bax mRNA levels of intestinal
mucosal tissue in the experimental groups significantly
increased compared with that of the normal control
group, (P <0.05). Bax mRNA level of intestinal mucosal
tissue in the model group was significantly higher than
that of the BA treatment group and the glutamine treat-
ment group, (P <0.05). Bax mRNA level of intestinal
mucosal tissue in the BA treatment group was signifi-
cantly lower than that of the glutamine group, (P < 0.05).
After treatment with BA, the activity of caspase-3 in
the intestinal mucosal of the baicalein group was signifi-
cantly lower than that of the model and the glutamine
group, (P <0.05) (Table 5) Fig. 4.
Discussions and conclusion
Intestinal mucosal cells are the body’s first line of
defense against endogenous substances such as bacteria,
viruses and endotoxin. Under normal circumstances, in-
testinal mucosal cells update once every 3–5 days, and
this balance process is maintained through apoptosis
and regeneration of intestinal mucosal cells. Once the
apoptosis of intestinal mucosal cells is greater than their
proliferation and then the intestinal barrier function is
damaged, so a large number of exogenous substances in-
cluding endotoxin enter the body to form endotoxemia
[30]. Liver cirrhosis is associated with decreased intestinal
mucosal proliferation and enterocyte apoptosis even at
early stages of cirrhosis liver disease [7]. Accumulating ex-
perimental and clinical evidences suggest that intestinal
Table 2 Comparison of blood endotoxin, ALT, AST and TBIL levels of rats in each group (x  s, Pg/ml, U/L, U/L, μmol/L)
Group N Endotoxin ALT AST TBIL
NG 10 3.78 ± 2.47 b c 28.21 ± 3.02 b c 26.83 ± 6.12 b 6.93 ± 0.29 b c
MG 20 115.12 ± 46.86 a 117.63 ± 15.82 a c 192.61 ± 29.65 a 24.51 ± 3.29 a
GG 20 96.29 ± 39.20a 75.12 ± 5.02 a b 83.84 ± 5.88 a b 13.82 ± 0.73 a b
BAG 20 38.27 ± 4.67bc 71.21 ± 4.02 a b 86.43 ± 6.28 a b 13.75 ± 0.86 a b
F endotoxin = 52.89, F ALT = 223.49, F AST = 223.49, F TBIL =234.90
aCompared with the normal control group, P < 0.05
bCompared with the model group, P < 0.05
cCompared with the glutamine group, P < 0.05
Table 3 The intestinal mucosal cell apoptosis rate of rats in
each group (x  s, %)
Groups Rat number Apoptosis rate
Normal control group (NG) 10 4.80 ± 1.92bc
Model group (MG) 20 48.80 ± 6.98ac
Glutamine group (GG) 20 16.00 ± 2.92ab
BA group (BAG) 20 12.80 ± 2.17abc
F = 339.39
aCompared with the normal control group, P < 0.05
bCompared with the model group, P < 0.05
cCompared with the glutamine group, P < 0.05
A B
C D
Fig. 3 The intestinal mucosal cell apoptosis in the each group after
treatment (TUNLE staining, 10 × 40). Note: a The pathological
changes of liver tissue in normal group; b The pathological changes
of liver tissue in Model group; c The pathological changes of liver
tissue in Glutamine treatment group; d The pathological changes of
liver tissue in BA treatment group
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barrier dysfunction and subsequent gut-derived endotoxe-
mia represent an important common pathogenetic mech-
anism in the development of diverse complications of
cirrhosis [31]. It is also possible that a cycle develops be-
tween intestinal damage and liver injury through the portal
circulation [32,33]. Thus the vicious cycle of endotoxemia
- intestinal mucosal injury is formed to promote disease
progression. When the condition of liver cirrhosis can not
be changed, the integrity of intestinal mucosa has become
the key to the treatment of disease [16,17].
Scutellaria root is dried root of Labiatae perennial herb
– Scutellaria baicalensis Georgi, and its nature is bitter
cold. It can enter the lung, stomach, gall bladder and
large intestine channels. It has the function of clearing
heat, eliminating damp, purging fire and removing toxin
in traditional Chinese medicine. In clinical applications,
it has been found that BA preparation has certain clin-
ical efficacy on endotoxemic cirrhotic patients, and basic
researches also confirmed that BA extracts could protect
liver cells and had anti-endotoxin function [16,17].
Our experiment showed that intestinal mucosal apop-
tosis rate of cirrhotic rats was significantly higher than
that of the normal control group. And after treatment
with BA, we found that the intestinal mucosal apoptosis
rate of cirrhotic rats and the endotoxin level were de-
creased. Though with the current study design, it is difficult
to determine whether intestinal mucosal cell apoptosis is
closely related with the formation of endotoxemia. And un-
fortunately, so far, no relevant studies could directly prove a
direct causal relationship between endotoxin and intestinal
mucosal cell apoptosis. But no matter which happens first,
BA undoubtedly contributes to the treatment of cirrhotic
endotoxemia to reduce intestinal mucosal apoptosis and re-
duce endotoxin levels.
Bcl-2 family is a group of apoptosis-related genes, in-
cluding Bcl-2, Bal-xl, Bcl-xs, Bax, etc. Bcl-2 and Bax is a
pair of genes that are most closely related with apop-
tosis, and both genes are present as homodimers re-
spectively, and they can also form heterodimers [34,35].
When intracellular Bax is highly expressed, cells are sen-
sitive to death signals and cell apoptosis is accelerated.
When Bcl-2 is highly expressed, Bcl-2 can form hetero-
dimers with Bax to inhibit apoptosis [36,37]. When Bax
homodimers are formed, they will induce apoptosis.
With Bcl-2 expression increasing, more and more Bax di-
mers separate to form more stable Bax-Bcl-2 heterodi-
mers with Bcl-2 than Bax-Bax, thereby inhibiting Bax-Bax
induced apoptosis, and therefore the ratio of intracellular
Bax to Bcl-2 is an important factor in the regulation of
apoptosis.
In our study RT-PCR results showed that the mRNA
level of anti-apoptotic gene Bcl-2 was the lowest in in-
testinal mucosal tissues of the model group while it was
the highest in the BA treatment group among the treat-
ment groups; while the mRNA level of pro-apoptotic
gene Bax was the lowest in the BA group while it was the
highest in the model group among the treatment groups
(Fig. 4). There are similar results in the treatment of other
diseases by BA [14,26]. This result indicated that BA could
reduce the expression of pro-apoptotic gene Bax, and sim-
ultaneously increase the expression of anti-apoptotic gene
Bcl-2, and finally might improve the ratio of Bcl-2/Bax to
inhibit the apoptosis of intestinal mucosal cells, thereby
reducing the formation of endotoxemia.
Some evidences have showed that the glutamine with
protective effect on intestinal mucosa barrier injury can
reduce the apoptosis of intestinal mucosal epithelial cells
[38-41]. So in our study it was made as a control group.
The Caspases family protease is core components of
apoptotic pathways. Caspase-8, Caspase-9 and Caspase-
12 respectively act as molecular switch in the pathway of
cell surface death receptor (extrinsic pathway), the mito-
chondrial /Cyt-c pathway (intrinsic pathway) and the
endoplasmic reticulum pathway. Caspase-3, as the apop-
tosis effector proteins, is a common downstream path-
way for three ways of cell apoptosis, and it plays a
decisive role in the apoptosis signal transduction path-
way. So we studied the changes of intestinal mucosal
Caspase-3 after the treatment by baicalin, and the results
showed that Caspase-3 was decreased after the treat-
ment in both the baicalin treatment group and the glu-
tamine group. Current studies suggest that for apoptosis,
there exists three pathways such as extrinsic pathway, in-
trinsic pathway or mitochondrial pathway and endoplasmic
Table 4 Bcl-2 mRNA relative expression levels of intestinal
mucosal tissues in each group (x  s, copies/ml)
Groups N Bcl-2 mRNA Bax mRNA
Normal control group (NG) 10 1.73 ± 0.12bc 0.52 ± 0.12bc
Model group (MG) 20 0.50 ± 0.13ac 1.87 ± 0.11 ac
Glutamine group (GG) 20 0.76 ± 0.13 ab 0.79 ± 0.14ab
BA group (BAG) 20 0.98 ± 0.11abc 0.66 ± 0.13abc
F Bcl-2 = 10.48, F Bax = 20.41
aCompared with the normal control group, P < 0.05
bCompared with the model group, P < 0.05
cCompared with the glutamine group, P < 0.05
Table 5 Changes of activity of caspase-3 in intestinal
mucosal tissues in each group (x  s)
Groups N caspase-3
Normal control group (NG) 10 289.11 ± 34.75bc
Model group (MG) 20 1076.23 ± 28.71ac
Glutamine group (GG) 20 578.35 ± 96.37ab
BA group (BAG) 20 420.21 ± 44.81abc
F caspase-3 = 525.39
aCompared with the normal control group, P < 0.05
bCompared with the model group, P < 0.05
cCompared with the glutamine group, P < 0.05
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reticulum pathway [42-44], and these three kinds of path-
ways are interconnected, so it is very complex. So what is
really the pathway through which baicalin alleviated intes-
tinal epithelial cell apoptosis, which is still in our research.
In our study, the apoptosis rate of intestinal mucosal
epithelial cells and the serum endotoxin levels in the BA
treatment group were significantly lower than that of the
glutamine treatment group, which suggested that BA
had a stronger ability to protect intestinal mucosal cells
and to make endotoxin levels decrease. More interesting
things were that in Table 2 the intestinal mucosal apop-
tosis in both the glutamine group and the BA group was
significantly reduced compared to the model control
group, yet in Table 1 it appeared that endotoxin levels
were quite different between the glutamine and BA
treatment groups. While there appears to be a significant
difference in intestinal apoptosis between the two groups,
it seems very minor, and much too small in relation to the
difference in endotoxin levels. Previous reports have dem-
onstrated that BA has shown a wide range of biological
activities, including antiendotoxic [10], anti-bacterial [11]
and anti-hepatic fibrosis [12,13]. That might be the reason.
In other words, Baicalin might reduce endotoxin levels
through a variety of ways, not just to reduce the intestinal
mucosal damage by reducing the apoptosis. Thus it makes
the baicalin much more hopeful in treating cirrhotic
endotoxemia.
Our study investigated the treatment effect of BA on
cirrhotic endotoxemia only from the perspective of
apoptosis, and more complete and in-depth results also
needs further research. But it showed that baicalein
might be a very promising drug in treating cirrhotic
endotoxemia.
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